NTRA

#442
Natera, Inc. Common Stock
213.54 USD
+5.77%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
206.36
215.00
Faixa anual
131.81
256.27
Mudança diária
+5.77%
Mudança mensal
+11.54%
Mudança em 6 meses
+23.26%
Mudança anual
+43.42%
Fechamento anterior
201.90
Abrir
207.81
Bid
Ask
Mínimo
206.36
High
215.00
Volume
166
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 30.27 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-150.72
Price to sales ratio
13.58

Natera Inc

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

Notícias